Check out your Company Bowl for anonymous work chats.
Sun and sandwiches anyone? We were thrilled to have so many members of the COMPASS London-based community join us for the UK company picnic on Friday. It was a delightful afternoon, creating memorable moments with colleagues away from our desks. We also bid a fond farewell to our co-founder Ekaterina Malievskaia, as she steps down from her executive role after six remarkable years, building COMPASS to where we are today. Thank you to Katya, and to everyone who made this day extra special.
Pioneering collaboration with King’s College London and South London and Maudsley NHS Foundation Trust
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced it is partnering with One Mind, a leading mental health research non-profit based in California, to sponsor three “2022 One Mind - COMPASS Rising Stars Awards”.
COMPASS Pathways plc announces financial results for third quarter 2020 Highlights include $146.6 million IPO, continued progress with phase IIb psilocybin therapy clinical trial, strengthened board and leadership team, and launch of Drug Discovery Center
COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care
COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares
COMPASS Pathways strengthens leadership team with appointment of Trevor Mill as Chief Development Officer.
